These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 24796620)
1. Urinary excretion of liver-type FABP as a new clinical marker for the progression of obstructive nephropathy. Xie Y; Xu W; Wang Q; Shao X; Ni Z; Mou S Biomark Med; 2014; 8(4):543-56. PubMed ID: 24796620 [TBL] [Abstract][Full Text] [Related]
2. Analysis of a urinary biomarker panel for obstructive nephropathy and clinical outcomes. Xie Y; Xue W; Shao X; Che X; Xu W; Ni Z; Mou S PLoS One; 2014; 9(11):e112865. PubMed ID: 25402279 [TBL] [Abstract][Full Text] [Related]
3. Urinary NGAL, KIM-1 and L-FABP concentrations in antenatal hydronephrosis. Noyan A; Parmaksiz G; Dursun H; Ezer SS; Anarat R; Cengiz N J Pediatr Urol; 2015 Oct; 11(5):249.e1-6. PubMed ID: 26096437 [TBL] [Abstract][Full Text] [Related]
4. Performance of urinary NGAL and L-FABP in predicting acute kidney injury and subsequent renal recovery: a cohort study based on major surgeries. Zeng XF; Li JM; Tan Y; Wang ZF; He Y; Chang J; Zhang H; Zhao H; Bai X; Xie F; Sun J; Zhang Y Clin Chem Lab Med; 2014 May; 52(5):671-8. PubMed ID: 24293449 [TBL] [Abstract][Full Text] [Related]
5. Urinary L-FABP and its combination with urinary NGAL in early diagnosis of acute kidney injury after cardiac surgery in adult patients. Liu S; Che M; Xue S; Xie B; Zhu M; Lu R; Zhang W; Qian J; Yan Y Biomarkers; 2013 Feb; 18(1):95-101. PubMed ID: 23167703 [TBL] [Abstract][Full Text] [Related]
6. Biomarkers of acute kidney injury in pediatric cardiac surgery. Peco-Antić A; Ivanišević I; Vulićević I; Kotur-Stevuljević J; Ilić S; Ivanišević J; Miljković M; Kocev N Clin Biochem; 2013 Sep; 46(13-14):1244-51. PubMed ID: 23876402 [TBL] [Abstract][Full Text] [Related]
7. Urinary KIM-1, NGAL and L-FABP for the diagnosis of AKI in patients with acute coronary syndrome or heart failure undergoing coronary angiography. Torregrosa I; Montoliu C; Urios A; Andrés-Costa MJ; Giménez-Garzó C; Juan I; Puchades MJ; Blasco ML; Carratalá A; Sanjuán R; Miguel A Heart Vessels; 2015 Nov; 30(6):703-11. PubMed ID: 24989970 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient. Xue W; Xie Y; Wang Q; Xu W; Mou S; Ni Z Nephrology (Carlton); 2014 Apr; 19(4):186-94. PubMed ID: 24165570 [TBL] [Abstract][Full Text] [Related]
9. Role of new biomarkers for predicting renal scarring in vesicoureteral reflux: NGAL, KIM-1, and L-FABP. Parmaksız G; Noyan A; Dursun H; İnce E; Anarat R; Cengiz N Pediatr Nephrol; 2016 Jan; 31(1):97-103. PubMed ID: 26324091 [TBL] [Abstract][Full Text] [Related]
10. Urinary neutrophil gelatinase-associated lipocalin and L-type fatty acid binding protein as diagnostic markers of early acute kidney injury after liver transplantation. Li Y; Zhu M; Xia Q; Wang S; Qian J; Lu R; Che M; Dai H; Wu Q; Ni Z; Lindholm B; Axelsson J; Yan Y Biomarkers; 2012 Jun; 17(4):336-42. PubMed ID: 22455661 [TBL] [Abstract][Full Text] [Related]
11. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients. Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388 [TBL] [Abstract][Full Text] [Related]
12. NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction. Holzscheiter L; Beck C; Rutz S; Manuilova E; Domke I; Guder WG; Hofmann W Clin Chem Lab Med; 2014 Apr; 52(4):537-46. PubMed ID: 24243749 [TBL] [Abstract][Full Text] [Related]
13. Non-inferiority of creatinine excretion rate to urinary L-FABP and NGAL as predictors of early renal allograft function. Pajek J; Škoberne A; Šosterič K; Adlešič B; Leskošek B; Bučar Pajek M; Osredkar J; Lindič J BMC Nephrol; 2014 Jul; 15():117. PubMed ID: 25027586 [TBL] [Abstract][Full Text] [Related]
14. The role of urinary liver-type fatty acid-binding protein in critically ill patients. Cho E; Yang HN; Jo SK; Cho WY; Kim HK J Korean Med Sci; 2013 Jan; 28(1):100-5. PubMed ID: 23341719 [TBL] [Abstract][Full Text] [Related]
15. NGAL (neutrophil gelatinase-associated lipocalin) and L-FABP after percutaneous coronary interventions due to unstable angina in patients with normal serum creatinine. Bachorzewska-Gajewska H; Poniatowski B; Dobrzycki S Adv Med Sci; 2009; 54(2):221-4. PubMed ID: 19875355 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of acute kidney injury biomarkers in pediatric cardiac surgery. Petrovic S; Bogavac-Stanojevic N; Lakic D; Peco-Antic A; Vulicevic I; Ivanisevic I; Kotur-Stevuljevic J; Jelic-Ivanovic Z Biochem Med (Zagreb); 2015; 25(2):262-71. PubMed ID: 26110039 [TBL] [Abstract][Full Text] [Related]
17. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD). Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709 [TBL] [Abstract][Full Text] [Related]
18. Urinalysis is more specific and urinary neutrophil gelatinase-associated lipocalin is more sensitive for early detection of acute kidney injury. Schinstock CA; Semret MH; Wagner SJ; Borland TM; Bryant SC; Kashani KB; Larson TS; Lieske JC Nephrol Dial Transplant; 2013 May; 28(5):1175-85. PubMed ID: 22529161 [TBL] [Abstract][Full Text] [Related]
19. Urine neutrophil gelatinase-associated lipocalin predicts graft outcome up to 1 year after kidney transplantation. Choi HM; Park KT; Lee JW; Cho E; Jo SK; Cho WY; Kim HK Transplant Proc; 2013; 45(1):122-8. PubMed ID: 23267793 [TBL] [Abstract][Full Text] [Related]
20. Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis. Meijer E; Boertien WE; Nauta FL; Bakker SJ; van Oeveren W; Rook M; van der Jagt EJ; van Goor H; Peters DJ; Navis G; de Jong PE; Gansevoort RT Am J Kidney Dis; 2010 Nov; 56(5):883-95. PubMed ID: 20888104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]